The tariff classification of a stationary oxygen concentrator from China
No revocation or modification of this ruling appears in the Customs Bulletin issues read here (Nov 6, 2024 through Nov 18, 2026), where CBP publishes most such actions. That is not confirmation that the ruling is still in effect. Confirm its status with CBP before relying on it (ruling on CBP CROSS).
Key passages, quoted from the ruling
- The applicable subheading for the stationary oxygen concentrator will be 9019.20.0000, Harmonized Tariff Schedule of the United States (HTSUS), which provides for “[o]zone therapy, oxygen therapy, aerosol therapy, artificial respiration or other therapeutic respiration apparatus; parts and accessories thereof.” The general rate of duty will be free.
Ruling text
In your letter dated May 12, 2025, you requested a tariff classification ruling on behalf of your client, Caire Inc. The product under consideration is the HomeStyle Aspen 5 L Stationary Oxygen Concentrator for use in a professional healthcare facility and/or home care environment. It measures 15 x 9 x 23.3 inches and weighs 32 lbs. The electrically powered device has a top handle and four wheels on the bottom. The unit’s front housing has a digital panel with timing and counts displayed for the end user.
It is intended as an oxygen supplement device (for adults only). The unit works by pulling room air through the concentrator by a small motor/compressor. The air goes through a heat exchanger and surge tank to pass through molecular sieve beads into a product tank. The oxygen is delivered to the user from the tank through a hose with help from a pressure regulator and flow meter valve.
The unit provides an oxygen flow rate of 0.5 - 5 L/min with an oxygen concentration level between 95.5 percent - 87 percent and has a minimum operating time of 15 minutes. You state that the device is specifically designed for the treatment of chronic respiratory conditions (such as COPD, pulmonary fibrosis, and other chronic lung diseases and disorders) and is only available for purchase directly from Caire or one of its health care distributors with a valid medical prescription.
The applicable subheading for the stationary oxygen concentrator will be 9019.20.0000, Harmonized Tariff Schedule of the United States (HTSUS), which provides for “[o]zone therapy, oxygen therapy, aerosol therapy, artificial respiration or other therapeutic respiration apparatus; parts and accessories thereof.” The general rate of duty will be free.
Effective March 4, 2025, pursuant to U.S. Note 2(u) to Subchapter III, Chapter 99, all products of China and Hong Kong as provided by heading 9903.01.24, HTSUS, other than products classifiable under headings 9903.01.21, 9903.01.22, and 9903.01.23, HTSUS, will be subject to an additional 20 percent ad valorem rate of duty. At the time of entry, you must report the applicable Chapter 99 heading, i.e. 9903.01.24, in addition to subheading 9019.20.0000, HTSUS, listed above.
Effective April 5, 2025, Executive Orders implemented “Reciprocal Tariffs.” All imported merchandise must be reported with either the Chapter 99 provision under which the reciprocal tariff applies or one of the Chapter 99 provisions covering exceptions to the reciprocal tariffs. At this time products from all countries will be subject to an additional 10 percent ad valorem rate of duty.
At the time of entry, you must report the Chapter 99 heading applicable to your product classification, i.e. 9903.01.25, in addition to subheading 9019.20.0000, HTSUS, listed above. However, the additional duties imposed by heading 9903.01.24 or 9903.01.25 shall not apply to goods for which entry is properly claimed under a provision of chapter 98 of the tariff schedule pursuant to applicable regulations of U.S.
The text above is an excerpt. The official ruling, with its letterhead, signature and any attachments, is on CBP CROSS (N348892).